ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft function"

  • 2021 American Transplant Congress

    Dual Lactate Clearance in the Liver Viability Assessment During Normothermic Machine Perfusion

    M. Xu1, F. Zhou1, O. Ahmed1, J. Shin1, Y. Zhu1, G. Upadhya1, K. Byrnes2, B. Wong1, J. Kim1, Y. Lin1, W. Chapman1

    1Department of Surgery, Washington University, St. Louis, MO, 2Department of Pathology and Immunology, Washington University, St. Louis, MO

    *Purpose: Liver normothermic machine perfusion (NMP) has been increasingly performed as a tool of organ preservation and to evaluate donor function. The perfusate lactate clearance…
  • 2021 American Transplant Congress

    Predicting Post-transplant Death and Graft Loss Risk: Insight at Listing

    N. Dzebisashvili1, M. Schnitzler2, K. Lentine2, K. Venkataramani1, S. Ghosh1

    1CareDx, Brisbane, CA, 2Saint Louis University, St. Louis, MO

    *Purpose: Prognostication models for post-transplant outcomes deriving inputs from information collected on donor (DDR/LDR), candidate (TCR) and transplant recipient (TRR) registrations can provide useful information…
  • 2021 American Transplant Congress

    Efficacy of Ex Vivo Normothermic Limb Perfusion in Maintaining Cellular Viability and Muscle Function

    T. Xia1, P. Sadeghi2, V. Kopparthy2, S. Pandey2, A. Rampazzo2, B. Bassiri Gharb2

    1School of Medicine, Case Western Reserve University, Cleveland, OH, 2Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH

    *Purpose: The purpose of this study was to evaluate cellular injury and myocyte function of amputated limbs following ex vivo normothermic limb perfusion (EVNLP) compared…
  • 2021 American Transplant Congress

    Role of Serial Donor Derived Cell-Free DNA Monitoring in Kidney Transplant Recipients

    A. X. Wang, C. R. Lenihan

    Nephrology, Stanford University School of Medicine, Palo Alto, CA

    *Purpose: Donor derived cell-free DNA (dd cf-DNA; Allosure, CareDx) is increasingly employed for non-invasive kidney transplant monitoring. The goal of this study was 1) to…
  • 2021 American Transplant Congress

    Dynamic Forecasting of Patient-Specific Kidney Transplant Function with a Sequence-to-Sequence Deep-Learning Model

    E. Van Loon1, W. Zhang2, A. Van Craenenbroeck1, B. De Moor2, M. Naesens1

    1Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium, 2ESAT Stadius Center for Dynamical Systems, Signal Processing and Data Analytics, KU Leuven, Leuven, Belgium

    *Purpose: Alike other clinical biomarkers, eGFR trajectories are characterized by intra-individual variability, related to biological fluctuations and analytical error. These fluctuations hamper the distinction between…
  • 2021 American Transplant Congress

    Donor-derived Cell-free DNA Distinguishes Acute Rejection from Other Causes of Graft Injury in Liver Transplant Recipients

    J. Levitsky1, M. Miller2, R. Sinha2, E. Bixler2, A. Al-Turck2, J. Weems2, M. Altrich2, S. Kleiboeker2, M. Abecassis3

    1Gastroenterology & Hepatology; Comprehensive Transplant Center, Northwestern University, Chicago, IL, 2Viracor Eurofins, Lees Summit, MO, 3University of Arizona College of Medicine Tucson, Tucson, AZ

    *Purpose: The donor derived cell-free DNA (ddcfDNA) has emerged as strong biomarker for allograft injury, where the fraction of ddcfDNA is reported to increase in…
  • 2021 American Transplant Congress

    Tissue Specific Antigen-presentation in VCA Transplantation

    B. Kern1, J. Mengwasser1, A. Reutzel-Selke1, M. I. Ashraf1, D. Polenz1, K. Fuehrer1, S. Lippert1, P. Tang1, F. Martin1, C. Witzel1, I. M. Sauer1, J. Pratschke1, S. G. Tullius2

    1Dept. of Surgery, Charité Campus CCM|CVK, Universitaetsmedizin Berlin, Germany, Berlin, Germany, 2Division of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    *Purpose: Vascular Composite Tissue Allotransplantation (VCA) has become a clinical reality. High frequencies of acute rejections remain an unsolved problem. Here, we delineated components of…
  • 2021 American Transplant Congress

    Clinical Effect of Post-transplant Av-fistula Ligation on Hemodynamic Status and Kidney Allograft Function

    S. Valavoor, J. Powelson, A. Sharfuddin, O. Adebiyi

    Nephrology, Indiana University, Indianapolis, IN

    *Purpose: Ligation of AVF post kidney transplant often done mostly for esthetic reasons, however, they are occasionally indicated in the presence severe steal syndrome, severe…
  • 2021 American Transplant Congress

    Donor-Derived Cell-Free DNA Can Differentiate Rejection versus Other Causes of Pancreas Transplant Dysfunction

    N. Ali1, J. Miles2, Z. Stewart Lewis1

    1Transplant Institute, NYU Langone Health, New York, NY, 2CareDx, Brisbane, CA

    *Purpose: Assessment and early detection of allograft injury in simultaneous pancreas and kidney (SPK) transplant recipients has clear benefits for optimizing treatment and intervention. Donor-derived…
  • 2021 American Transplant Congress

    Development of Diagnosis Method of Acute Graft Rejection After Kidney Transplantation Using Metabolome Analysis by Liquid Biopsy Approach

    H. Iwamoto1, M. Sugimoto2, O. Konno1, I. Akashi3, M. Okihara1, Y. Kihara1, T. Ueno1

    1Kidney Transplantation Surgery, Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan, 2Research and Development Center for Minimally Invasive and Preemptive Medicine, Institute of Medi, Tokyo Medical University, Tokyo, Japan, 3Kidney transplantation Surgery, Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan

    *Purpose: Presently, a definitive diagnosis of organ dysfunction after transplantation (such as acute rejection) is dependent on conventional histopathological evaluation using an invasive biopsy procedure…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 64
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences